Income Statement - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.83 |
| Cost of revenue | 0.62 | 0.60 | 0.54 | 0.47 | 0.13 | 0.01 | 0.00 |
| Gross profit | -0.62 | -0.60 | -0.54 | -0.47 | -0.13 | -0.01 | 0.00 |
| Total operating expenses | 78.85 | 61.79 | 77.65 | 67.59 | 35.83 | 8.55 | 1.91 |
| Operating income | -79.47 | -62.38 | -78.19 | -67.59 | -35.83 | -8.56 | -1.91 |
| Non-operating income (net) | 9.68 | 12.80 | 11.33 | 4.29 | 0.30 | 0.28 | -0.14 |
| Income before tax | -69.79 | -49.59 | -66.86 | -63.31 | -35.53 | -8.28 | -2.05 |
| Income tax expense | 0.00 | -4.69 | -0.11 | -0.20 | 0.14 | ||
| Net income | -69.79 | -49.59 | -66.86 | -58.62 | -35.53 | -8.28 | -2.05 |
Show Quarterly Income Statement
Income Statement - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.59 | 0.00 | 0.00 | 0.00 | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.03 | 0.14 |
| Cost of revenue | -14.74 | 14.59 | 0.15 | 0.16 | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.12 | 0.11 | 0.10 | 0.08 | 0.03 | 0.01 | 0.00 | 2.71 | 1.91 | 1.06 | 0.38 | |
| Gross profit | 14.74 | -14.59 | -0.15 | -0.16 | 0.29 | -0.15 | -0.15 | -0.14 | -0.14 | -0.14 | -0.14 | -0.14 | -0.14 | -0.12 | -0.11 | -0.10 | -0.08 | -0.03 | -0.01 | 0.00 | -2.68 | -1.89 | -1.03 | -0.24 | |
| Total operating expenses | 19.71 | 32.91 | 4.72 | 21.42 | 20.42 | 16.69 | 16.25 | 14.89 | 14.26 | 15.12 | 18.69 | 22.60 | 21.65 | 19.39 | 19.19 | 15.64 | 13.37 | 11.13 | 11.34 | 7.69 | 5.68 | 3.86 | 2.38 | 1.46 | 0.62 |
| Operating income | -19.71 | -18.17 | -19.31 | -21.57 | -20.42 | -16.69 | -16.25 | -15.04 | -14.40 | -15.12 | -18.82 | -22.60 | -21.65 | -19.39 | -19.19 | -15.64 | -13.37 | -11.13 | -11.34 | -7.69 | -5.68 | -3.86 | -2.38 | -1.46 | -0.62 |
| Non-operating income (net) | 2.07 | 2.17 | 2.31 | 2.49 | 2.70 | 3.04 | 3.21 | 3.25 | 3.30 | 3.28 | 3.03 | 2.66 | 2.36 | 2.05 | 1.49 | 0.64 | 0.11 | 0.06 | 0.02 | 0.05 | 0.17 | 0.01 | 0.06 | 0.02 | -0.04 |
| Income before tax | -17.64 | -16.00 | -17.00 | -19.08 | -17.72 | -13.65 | -13.04 | -11.79 | -11.11 | -11.84 | -15.79 | -19.94 | -19.29 | -17.34 | -17.70 | -15.00 | -13.27 | -11.07 | -11.32 | -7.64 | -5.51 | -3.86 | -2.32 | -1.44 | -0.66 |
| Income tax expense | 0.10 | 2.49 | -0.14 | 0.01 | -2.36 | -2.18 | -1.49 | -0.64 | -0.11 | -0.06 | -1.46 | -0.62 | |||||||||||||
| Net income | -17.64 | -16.00 | -17.00 | -19.08 | -17.72 | -13.65 | -13.04 | -11.79 | -11.11 | -11.84 | -15.79 | -19.94 | -19.29 | -17.34 | -17.70 | -15.00 | -13.27 | -11.07 | -11.32 | -7.64 | -5.51 | -3.86 | -2.32 | -1.44 | -0.66 |